Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116199614B reveals high ee synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel patent CN107011218A enables high ee value synthesis of chiral amines reducing steps and improving supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110156710B details a novel Pd-catalyzed route for polysubstituted oxazoles. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN107936025B enables mild synthesis of chiral pyrazolidones. Eliminates heavy metals for cost reduction and supply chain reliability in pharmaceutical manufacturing.
Novel glucose-based route for trifluoromethyl triazoles. Mild conditions, scalable, cost-effective pharmaceutical intermediates manufacturing solution.
Patent CN110156710B details a scalable Pd-catalyzed route for polysubstituted oxazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109293491B details a metal-free photochemical acylation method. Offers high yields up to 72% for pharmaceutical intermediates without transition metals.
Patent CN118126005B details metal-free synthesis of dihydrobenzofuran compounds offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel synthesis of Remdesivir intermediates via CN113214320A offers high purity and scalable manufacturing. Discover cost-effective supply chain solutions for antiviral API production.
Patent CN115286556B reveals green synthesis for indolinone esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110724164B discloses novel 3-substituted spiro ligands achieving 99% ee. Enables cost-effective API intermediate manufacturing with high TON.
Novel 4-step process for high-purity intermediates. Reduces complexity and enhances supply chain reliability for global manufacturers.
Patent CN112812084B reveals a cost-effective iron phthalocyanine catalyzed route for benzofuran intermediates, offering significant supply chain and purity advantages.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel palladium-catalyzed method offers significant cost reduction and high purity standards for global pharmaceutical intermediates manufacturing supply chains ensuring reliable delivery and operational efficiency.
Novel CuCl-catalyzed route for triazole arylamines. Enhances supply chain stability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel Pd-catalyzed method for 2-trifluoromethyl quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine. Cost-effective manufacturing solution.
Novel palladium-catalyzed carbonylation method offers cost reduction and scalable supply chain solutions for high-purity pharmaceutical intermediates manufacturing globally.
Novel chiral synthesis method offers high yield and enantioselectivity for antitumor drug intermediates, ensuring supply chain stability.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.